← Leaderboards
Jasper Smits
Massachusetts General Hospital
$5,956,982
Attributed
$14,038,872
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,038,872 · 9
By mechanism
R01$11,069,086 · 4
R34$2,539,411 · 4
R21$430,375 · 1
Top collaborators
- Michael J Zvolensky20 shared
- Conall Michael O'Cleirigh9 shared
- Marie H. Monfils4 shared
- Michael J. Telch4 shared
- Marshall Cheney3 shared
- Michael W. Otto3 shared
- Cara Calloway Young2 shared
- David I Rosenfield1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- A Eden Evins$20,295,171
- Michael J Zvolensky$15,215,289
- Michael A Schwarzschild$27,249,495
- Michael W. Otto$8,919,189
- Conall Michael O'Cleirigh$14,994,576
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultSmoking RelapseAnxietyAbstinenceRandomizedSmokerSmokingSmoking CessationSmoking Cessation InterventionDesignFollow-UpPrevalenceBasic ScienceNicotine ReplacementMaintenanceAnxiety DisordersProtocols DocumentationUnited StatesExposure ToMental DepressionSiteSmokeBaseRelapse
Grant awards (32)
1/2: CO2 Reactivity as a Biomarker of Non-response to Exposure-based Therapy$614,583
R01 · FY2025 · MH · contact PI
Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity$1
R01 · FY2025 · CA · contact PI
1/2: CO2 Reactivity as a Biomarker of Non-response to Exposure-based Therapy$723,040
R01 · FY2024 · MH · contact PI
Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity$516,606
R01 · FY2024 · CA · contact PI
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV$1,108,803
R01 · FY2023 · DA
1/2: CO2 Reactivity as a Biomarker of Non-response to Exposure-based Therapy$723,040
R01 · FY2023 · MH · contact PI
Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity$648,024
R01 · FY2023 · CA · contact PI
1/2: CO2 Reactivity as a Biomarker of Non-response to Exposure-based Therapy$763,817
R01 · FY2022 · MH · contact PI
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV$1,224,954
R01 · FY2021 · DA
Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV$9,742
R01 · FY2021 · DA
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV$1,060,548
R01 · FY2020 · DA
Isradipine and Virtual Reality Cue Exposure for Smoking Cessation$195,625
R21 · FY2020 · DA
Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV$166,958
R01 · FY2020 · DA
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV$1,183,997
R01 · FY2019 · DA
Isradipine and Virtual Reality Cue Exposure for Smoking Cessation$234,750
R21 · FY2019 · DA
Approach Bias Retraining to Augment Smoking Cessation$223,013
R34 · FY2019 · DA · contact PI
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV$13,170
R01 · FY2019 · DA
Approach Bias Retraining to Augment Smoking Cessation$223,013
R34 · FY2018 · DA · contact PI
Approach Bias Retraining to Augment Smoking Cessation$223,013
R34 · FY2017 · DA · contact PI
3/3-Dose Timing of D-cycloserine to Augment CBT for Social Anxiety Disorder$231,750
R34 · FY2016 · MH · contact PI
3/3-Dose Timing of D-cycloserine to Augment CBT for Social Anxiety Disorder$231,750
R34 · FY2015 · MH · contact PI
Enhancing Panic and Smoking Reduction Treatment with D-Cycloserine$199,549
R34 · FY2015 · DA · contact PI
3/3-Dose Timing of D-cycloserine to Augment CBT for Social Anxiety Disorder$231,750
R34 · FY2014 · MH · contact PI
Enhancing Panic and Smoking Reduction Treatment with D-Cycloserine$202,588
R34 · FY2014 · DA · contact PI
Enhancing Panic and Smoking Reduction Treatment with D-Cycloserine$219,750
R34 · FY2013 · DA · contact PI
Exercise Intervention for Smoking$535,188
R01 · FY2012 · DA
Integrated Treatment for Smoking Cessation & Anxiety in People with HIV$261,167
R34 · FY2012 · DA
Exercise Intervention for Smoking$41,160
R01 · FY2012 · DA · contact PI
Exercise Intervention for Smoking$566,782
R01 · FY2011 · DA · contact PI
Integrated Treatment for Smoking Cessation & Anxiety in People with HIV$292,068
R34 · FY2011 · DA
Exercise Intervention for Smoking$575,546
R01 · FY2010 · DA · contact PI
Exercise Intervention for Smoking$593,127
R01 · FY2009 · DA · contact PI